Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06142565
Other study ID # 2023-03779-01
Secondary ID 2021-06527
Status Recruiting
Phase N/A
First received
Last updated
Start date October 17, 2023
Est. completion date April 17, 2024

Study information

Verified date November 2023
Source Karolinska Institutet
Contact Johan N Lundström
Phone +46700913149
Email johan.lundstrom@ki.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A decreased sense of smell (hyposmia) is often caused by viral infections, such as COVID-19. Today, the only recommended treatment for hyposmia is olfactory training, a time consuming method with limitations in terms of both compliance and effect. The aim of this study is therefore to evaluate, as well as optimize, a new treatment method for olfactory loss. Hyposmic participants will be recruited and randomized into two different treatment conditions. One group will do regular olfactory training and the other will do passive olfactory training with scented nose plugs. The training will be conducted in the home of the individual monday through friday for two consecutive months. Subjective and objectvie measures of olfactory problems will be assessed before and after treatment, as well as subjective measures related to quality of live and genereal wellbeing.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date April 17, 2024
Est. primary completion date April 17, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - 18 - 65 years old - Physically and cognitively capable of participating in the study - Having appropriate olfactory screening test scores (hyposmic) Exclusion Criteria: - Anosmics - Individuals with other diagnoses that could affect the study results

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Nose plug
Participants will complete olfactory training with scented nose plugs.
Other:
Regular olfactory training
Participants will complete olfactory training with regular odors found in their home.

Locations

Country Name City State
Sweden Karolinska Institutet Solna Stockholm

Sponsors (2)

Lead Sponsor Collaborator
Karolinska Institutet Region Skane

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Objective olfactory function Does the use of scented nose plugs increase the effect of olfactory training on objective olfactory function compared to regular olfactory training? For this outcome, we will use the standardized Sniffin' Sticks test to assess olfactory function. 2 months
Primary Subjective symptoms and social/emotional consequences Does the use of scented nose plugs increase the effect of olfactory training on subjective symptoms and social/emotional consequences compared to regular olfactory training? For this outcome, we will use the Sino-Nasal Outcome Test (SNOT). 2 months
Primary Subjective health Does the use of scented nose plugs increase the effect of olfactory training on subjective health compared to regular olfactory training? For this outcome, we will use the Self-Rated Health 5 measure and SF-36. 2 months
Primary Subjective olfactory function Does the use of scented nose plugs increase the effect of olfactory training on subjective olfactory function compared to regular olfactory training? For this outcome, we will use the Self-Reported Mini Olfactory Questionnaire. 2 months
Primary Subjective degree of suffering from olfactory impairment Does the use of scented nose plugs increase the effect of olfactory training on subjective degree of suffering from olfactory impairment compared to regular olfactory training? For this outcome, we will use the Questionnaire of Olfactory Disorders - Negative Statements. 2 months
Primary Subjective parosmia Does the use of scented nose plugs increase the effect of olfactory training on subjective parosmia compared to regular olfactory training? For this outcome, we will use the Landis parosmia questionnaire. 2 months
Primary Subjective depressive symptoms Does the use of scented nose plugs increase the effect of olfactory training on depressive symptoms compared to regular olfactory training? For this outcome, we will use the Beck Depression Inventory (BDI). 2 months
Primary Subjective general wellbeing Does the use of scented nose plugs increase the effect of olfactory training on depressive symptoms compared to regular olfactory training? For this outcome, we will use the General Well Being Schedule. 2 months
Primary Compliance Does the use of scented nose plugs increase the compliance of olfactory training compared to regular olfactory training? For this outcome, we will use questions asking the participants about their experience during the olfactory training, specifically targeting their compliance, such as how often they actually completed the olfactory training and how often they forgot to. 2 months
See also
  Status Clinical Trial Phase
Recruiting NCT06019000 - Study of CYR-064 Versus Placebo in Patients. Phase 2
Completed NCT05445921 - Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction Phase 1/Phase 2
Completed NCT04853836 - Olfactory Disfunction and Co-ultraPEALut Phase 4
Completed NCT05152030 - The Clinical Applicability of the 'TIB' Olfactory Test Device
Recruiting NCT05837637 - The Vietnamese Smell Identification Test in the Diagnosis of Parkinson's Disease
Recruiting NCT05384561 - Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19 N/A
Not yet recruiting NCT04661800 - Study of Olfactory Disorders in Patients With Cardiac Amyloidosis N/A
Completed NCT04789499 - Smell in Covid-19 and Efficacy of Nasal Theophylline Phase 2
Recruiting NCT05364125 - Olfactory Training on Smell Dysfunction Patients in HK N/A
Completed NCT05461365 - Intranasal Insulin for COVID-19-related Smell Loss Phase 3
Completed NCT04710394 - Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell N/A
Completed NCT05184192 - Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction Phase 2
Not yet recruiting NCT05421221 - Olfactory Training in COVID-19 Associated Loss of Smell N/A